BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+10.14%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$690M
AUM Growth
+$690M
(-3.2%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
57.65%
Holding
63
New
10
Increased
12
Reduced
21
Closed
11
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$16.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$14.5M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$14.1M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$12.3M |
| 5 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$11.7M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$19M |
| 2 |
ADXS
Advaxis, Inc.
ADXS
|
$12.4M |
| 3 |
MDCO
Medicines Co
MDCO
|
$10.5M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$9.14M |
| 5 |
DURECT Corp
DRRX
|
$8.93M |
Sector Composition
| 1 | Healthcare | 89.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Heron Therapeutics
HRTX
$207M
| $61.2M | 7.43% | 4,418,359 -529,044 | -11% | -$7.33M |
|
2
Travere Therapeutics
TVTX
$1.56B
| $55.5M | 6.74% | 2,862,178 -30,000 | -1% | -$582K |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $48.2M | 5.86% | 4,060,847 -1,603,372 | -28% | -$19M |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $45.6M | 5.54% | 4,133,464 -261,000 | -6% | -$2.88M |
|
|
PETX
5
DELISTED
Aratana Therapeutics, Inc.
PETX
| $37.5M | 4.55% | 5,184,942 +1,489,500 | +40% | +$10.8M |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $37.4M | 4.55% | 1,257,887 +475,000 | +61% | +$14.1M |
|
|
CORI
7
DELISTED
Corium International, Inc.
CORI
| $33.1M | 4.02% | 4,436,726 +1,649,605 | +59% | +$12.3M |
|
|
RXDX
8
DELISTED
Ignyta, Inc.
RXDX
| $30.4M | 3.7% | 2,941,247 +303,901 | +12% | +$3.15M |
|
9
AngioDynamics
ANGO
$417M
| $27.3M | 3.31% | 1,683,252 +217,800 | +15% | +$3.53M |
|
|
SCTL
10
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $21.8M | 2.65% | 3,100,086 | – | – |
|
|
SBBP
11
DELISTED
Strongbridge Biopharma plc.
SBBP
| $20.5M | 2.49% | 2,871,928 -109,778 | -4% | -$785K |
|
12
Catalyst Pharmaceutical
CPRX
$2.52B
| $20.3M | 2.46% | 7,350,000 -850,000 | -10% | -$2.35M |
|
|
NVLN
13
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $18M | 2.18% | 1,948,554 | – | – |
|
14
Iovance Biotherapeutics
IOVA
$807M
| $16.7M | 2.03% | 2,276,359 -232,700 | -9% | -$1.71M |
|
|
AERI
15
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $16.3M | 1.98% | +310,000 | New | +$16.3M |
|
|
ATRS
16
DELISTED
Antares Pharma, Inc.
ATRS
| $15.5M | 1.88% | 4,803,528 -2,838,678 | -37% | -$9.14M |
|
|
17
Alnylam Pharmaceuticals
ALNY
$58.5B
| $14.5M | 1.76% | +181,200 | New | +$14.5M |
|
|
BDSI
18
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $14.3M | 1.74% | 5,122,094 -276,700 | -5% | -$775K |
|
|
ENDP
19
DELISTED
Endo International plc
ENDP
| $13.9M | 1.69% | 1,246,923 -636,815 | -34% | -$7.11M |
|
|
TLGT
20
DELISTED
Teligent, Inc
TLGT
| $13.4M | 1.63% | 1,467,452 -464,259 | -24% | -$4.25M |
|
21
Veracyte
VCYT
$2.39B
| $12.1M | 1.46% | 1,446,866 -201,700 | -12% | -$1.68M |
|
|
NVDQ
22
DELISTED
Novadaq Technologies Inc.
NVDQ
| $11.7M | 1.42% | +1,000,000 | New | +$11.7M |
|
|
AMRN
23
Amarin Corp
AMRN
$311M
| $10.2M | 1.24% | 2,533,649 -300,000 | -11% | -$1.21M |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.09M | 1.1% | 2,490,801 +400,000 | +19% | +$1.46M |
|
|
JUNO
25
DELISTED
Juno Therapeutics, Inc.
JUNO
| $7.83M | 0.95% | 262,100 +86,400 | +49% | +$2.58M |
|